Logo image of SEV

SONO GROUP NV (SEV) Stock Fundamental Analysis

NASDAQ:SEV - Nasdaq - NL0015000N74 - Common Stock - Currency: USD

0.207  -0.02 (-8.33%)

After market: 0.2 -0.01 (-3.38%)

Fundamental Rating

2

SEV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. SEV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SEV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SEV has reported negative net income.
SEV Yearly Net Income VS EBIT VS OCF VS FCFSEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 -20M -40M -60M

1.2 Ratios

The profitability ratios for SEV are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEV Yearly ROA, ROE, ROICSEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 200 400 600 800 1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SEV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEV Yearly Profit, Operating, Gross MarginsSEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 -100K -200K -300K

More info and screens

4

2. Health

2.1 Basic Checks

SEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SEV has been increased compared to 1 year ago.
SEV has a better debt/assets ratio than last year.
SEV Yearly Shares OutstandingSEV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 20M 40M 60M
SEV Yearly Total Debt VS Total AssetsSEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 50M 100M

2.2 Solvency

Based on the Altman-Z score of -5.13, we must say that SEV is in the distress zone and has some risk of bankruptcy.
SEV has a Altman-Z score of -5.13. This is amonst the worse of the industry: SEV underperforms 95.24% of its industry peers.
SEV has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
SEV has a better Debt to Equity ratio (0.24) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -5.13
ROIC/WACCN/A
WACC6.5%
SEV Yearly LT Debt VS Equity VS FCFSEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.93 indicates that SEV has no problem at all paying its short term obligations.
SEV has a Current ratio of 2.93. This is in the better half of the industry: SEV outperforms 66.67% of its industry peers.
A Quick Ratio of 2.93 indicates that SEV has no problem at all paying its short term obligations.
SEV has a Quick ratio of 2.93. This is amongst the best in the industry. SEV outperforms 80.95% of its industry peers.
Industry RankSector Rank
Current Ratio 2.93
Quick Ratio 2.93
SEV Yearly Current Assets VS Current LiabilitesSEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 50M 100M

More info and screens

3

3. Growth

3.1 Past

SEV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.76%.
EPS 1Y (TTM)-31.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 3.33% on average over the next years.
The Revenue is expected to grow by 745.34% on average over the next years. This is a very strong growth
EPS Next Y4.23%
EPS Next 2Y34.27%
EPS Next 3Y8.62%
EPS Next 5Y3.33%
Revenue Next Year9900%
Revenue Next 2Y1691.95%
Revenue Next 3Y2072.21%
Revenue Next 5Y745.34%

3.3 Evolution

SEV Yearly Revenue VS EstimatesSEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
SEV Yearly EPS VS EstimatesSEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SEV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SEV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEV Price Earnings VS Forward Price EarningsSEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEV Per share dataSEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.27%
EPS Next 3Y8.62%

More info and screens

0

5. Dividend

5.1 Amount

SEV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SONO GROUP NV

NASDAQ:SEV (7/20/2023, 8:20:59 PM)

After market: 0.2 -0.01 (-3.38%)

0.207

-0.02 (-8.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)06-21 2023-06-21/amc
Earnings (Next)N/A N/A
Inst Owners39.89%
Inst Owner ChangeN/A
Ins Owners0.6%
Ins Owner Change0%
Market Cap18.19M
Analysts77.14
Price Target2.69 (1199.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-66.87%
Min EPS beat(2)-80.62%
Max EPS beat(2)-53.11%
EPS beat(4)0
Avg EPS beat(4)-49.12%
Min EPS beat(4)-80.62%
Max EPS beat(4)-13.62%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-77.1%
Min Revenue beat(2)-81.01%
Max Revenue beat(2)-73.19%
Revenue beat(4)0
Avg Revenue beat(4)-82.51%
Min Revenue beat(4)-91.68%
Max Revenue beat(4)-73.19%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)32.99%
EPS NQ rev (1m)-29.82%
EPS NQ rev (3m)-24.72%
EPS NY rev (1m)49.44%
EPS NY rev (3m)49.44%
Revenue NQ rev (1m)37.79%
Revenue NQ rev (3m)40.93%
Revenue NY rev (1m)167.91%
Revenue NY rev (3m)167.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 76.48
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)-2.92
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.36
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.93
Quick Ratio 2.93
Altman-Z -5.13
F-ScoreN/A
WACC6.5%
ROIC/WACCN/A
Cap/Depr(3y)269.07%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y4.23%
EPS Next 2Y34.27%
EPS Next 3Y8.62%
EPS Next 5Y3.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year9900%
Revenue Next 2Y1691.95%
Revenue Next 3Y2072.21%
Revenue Next 5Y745.34%
EBIT growth 1Y-9.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-105.52%
EBIT Next 3Y15.2%
EBIT Next 5Y37%
FCF growth 1Y-3873.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3874.79%
OCF growth 3YN/A
OCF growth 5YN/A